2m 2m 2m 2m 2m 2m 2m
Kura Oncology (KURA)
NASDAQ
$7.74+$0.17 (+2.25%)
Price as of Nov 11, 2026 7:32 PM EST- $673.4MMarket Cap
- -29.19%1-Year Change
- BiotechnologyIndustry
Kura Oncology (KURA)
$7.74+$0.17 (+2.25%)
KURA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $7.57 | ||
Change | $0.00 (0.00%) | ||
Open | $7.57 | ||
High | $7.86 | ||
Low | $7.29 | ||
Previous Close | $7.57 | ||
Volume | 2,502,483 | ||
30-Day Average Volume | 2,174,572 | ||
1-Week Change | -23.38% | ||
1-Month Change | -28.58% | ||
1-Year Change | -29.19% | ||
3-Year Change | -11.15% | ||
5-Year Change | -57.66% | ||
Fundamentals | |||
Shares Outstanding | 89.0M | ||
Total Assets | $566.5M | ||
Market Cap | $673.4M | ||
Enterprise Value | $625.3M | ||
Period: QTR TTM FY | |||
Revenue | $13.9M | ||
Net Income | -$70.2M | ||
Free Cash Flow | -$54.9M | ||
EBIT | -$70.2M | ||
EBITDA | -$69.9M | ||
Net Working Capital | $386.0M | ||
EPS | -$0.78 | ||
Enterprise Value/EBITDA | -9 | ||
Enterprise Value/Revenue | 45 | ||
P/B | 37 | ||
P/E | -10 | ||
PEG | 7 | ||
Price/Free Cash Flow | -12 | ||
Price/Operating Cash Flow | -12 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue